We review here various ways in which cardiac assistance might be derived from a patient's own skeletal muscle.
periods. Such For some years the surgical treatment of end stage cardiac failure has been restricted to cardiac transplantation and the temporary use of mechanical circulatory support devices as a bridge to transplant. The discovery that adult fast-twitch mammalian skeletal muscle is capable of undergoing adaptive change, through which it can acquire a markedly increased resistance to fatigue, has revived interest in the possibility of diverting skeletal muscle from its normal function to perform in a cardiac assist role.
The adaptive transformation of skeletal muscle that takes place in response to increased use has been studied extensively'-' and it is not proposed to describe it in any detail here. The important elements can, however, be stated quite simply. A muscle will be resistant to fatigue if it can supply, on a continuous basis, sufficient ATP to meet the prevailing energy costs of contraction. These costs derive mainly from the cyclic turnover of chemical bonds between actin and myosin and the transport of calcium between intracellular compartments. Skeletal muscle that has been conditioned by long-term electrical stimulation acquires more favourable bioenergetics for sustained contraction as a result of changes both in the isoforms of myosin and in the kinetics of the release and uptake of calcium. At the same time, sustained production of ATP becomes possible through an increase in the capacity of oxidative pathways, particularly those involved in the breakdown of fat and fatty acids, at the expense of anaerobic glycolysis. There is an associated increase in capillary blood supply and mitochondrial volume. As a result, the production of ATP can match even the extreme increases in the utilisation of ATP required for the performance of cardiac work.' Four approaches to skeletal muscle assist There are several ways in which we can try to harness the power of conditioned skeletal muscle for cardiac assistance but they fall into two major categories (fig 1) . CATEGORY 
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The combined effect of these losses is a reduction in power output to about 10% of control values '7 18 (fig 3, lower curve) . This looks rather serious until it is recognised that in absolute terms the maximal acute power output of the stimulated muscle is still 30-40 W/kg, close to the systolic power of the left ventricular myocardium. These power outputs refer only to the rate at which work is performed during contraction. In any practical application, the muscle must spend at least as much time in relaxation as in contraction, and since work is available only during contraction the maximum power output is about 20 W/kg. At the specified work rates of 2-1-5 W/kg, then, the stimulated muscle would be working at 10-20% of the maximum. To what extent can such working rates be sustained?
We have conducted fatigu,e tests on the same rabbit TA muscles under conditions in which they were constrained to perform external work at 10 W/kg. Conditioned muscles were able to maintain this level of work for many hours whereas control muscles showed progressive fatigue at the same initial work rate, even though their maximum power capacity was much greater. Although we have not run such tests at much higher rates of working, we doubt whether such rates could be sustained for more than short periods.
10 W/kg has to be regarded as an overestimate because it is based on rabbit muscle; the specific power of human muscle is intrinsically less, because of its slower contractile characteristics.'9 The difference in power may be less marked when the comparison is made between human and rabbit muscles that are fully conditioned for continuous use, but it would seem sensible to allow for a reduction to 8 W/kg. The actual mass of muscle finally generating work will also be less than the starting mass, for several reasons. First, there is the loss ofmuscle bulk, already referred to, that is the consequence of performing work continuously at this high level; this stabilises at approximately 50% in the long term.6 This would reduce the working mass of a muscle such as latissimus dorsi to about 300 g. Second, there is a loss associated with the grafting procedure. The experiments of Guerlinckx et af20 on orthotopic grafting of rabbit rectus femoris muscles suggest that a chronic reduction in mass of 25% would be expected as a result of tendon section alone. This would bring about a further reduction to about 225 g. To this must be added any loss of muscle fibres through ischaemic damage. The power available would therefore be unlikely to exceed 1-8 W.
Recent work from our laboratory suggests that conditioning regimens can be devised that are very much better at preserving muscle mass and contractile speed, and hence the maximum power available in the long term.2' 22 There is less scope for such techniques when the energy demand is continuously high, but they may be useful under partial assist conditions-for example, when only a proportion of the patient's heart beats are assisted. Procedures based on reconfiguration of skeletal muscle alone have considerable advantages over any approach that requires the muscle to be interfaced with non-biological materials (see below). Of these procedures cardiomyoplasty and aortomyoplasty suffer from one serious limitation: the geometry of the pump is dictated by the size and shape of the existing organs. In some ways the consequences of this limitation are obvious: a grossly hypertrophied heart may be too large to be wrapped effectively by the patient's latissimus dorsi muscle; the small lumen of the aorta restricts the stroke volume that can be achieved by compressing it. But just as important as these anatomical considerations are the loading conditions that the fixed geometry imposes on the muscle wrap, because they constrain the muscle to operate far from the peak ofits power curve.723 The benefits that have been reported by patients who have had the cardiomyoplasty procedure may be due to the reinforcement given to the myocardial wall, or to the translational motion imparted by contraction of the free portion of the graft.23
In contrast, the SMV approach is limited only by the size, shape, and fibre orientation of the latissimus dorsi (or other muscle) that is available. Subject only to these limitations, factors such as cavity volume, wall thickness, and direction of wrap are all within the control of the surgeon and can, given the appropriate basic knowledge, be optimised to provide the maximum pumping performance of which the muscle is capable. Set against this functional potential is the need to ensure that the introduction of such a device into the patient's circulation does not cause thrombus formation, with the attendant risks of obstruction of flow through the device and embolism to vital organs.
CONFIGURATIONS IN WHICH SKELETAL MUSCLE IS COUPLED INDIRECTLY TO THE CIRCULATION
It is possible to envisage several ways in which a skeletal muscle could, in principle, provide the energy for a mechanical assist device, such as a left ventricular assist device (LVAD).
(a) Direct mechanical linkage ( fig 2F) would be moderately efficient, especially if the muscle were allowed to operate in its normal line of action and without disturbance to its vascular supply. Problems would be the need for the assist device to be close to the muscle and the difficulty of creating a strong and reliable junction between a muscle and a non-biological surface. The latter is not a trivial matter: even tendon-to-tendon anastomoses take many months to acquire full strength. Furthermore, the junction must be capable of unimpeded translational movement and must remain so.
(b) A hydraulic link could be established by wrapping a muscle around a fluid-filled bladder4 (fig 2G) or, more conservatively, by arranging for the bladder to divert the muscle from its normal line of action, so that it was compressed when the muscle contracted25 ( fig  2G) . This approach would allow a little more freedom in the placement of the assist device relative to the muscle, at the cost of some resistive energy losses in the coupling lines. However, all existing biopolymers are permeable to some extent, so that in the present state of development it would not be possible to avoid a progressive escape of fluid from the system. This problem has yet to be overcome.
(c) An indirect approach (fig 2H) , in which contraction of the muscle was coupled to the generation of electricity, has several advantages. It is the most flexible arrangement in terms of placement: for example, an intrathoracic device might be powered by a muscle in the lower limb. There would be a broader choice of assist device, and this could encompass electrically driven devices that had not been designed with skeletal muscle power specifically in mind. However, such an approach poses technological problems that await a reliable solution, and these include the problems of muscle attachment already mentioned.
With an optimistic estimate of50% efficiency for the energy conversions involved, the maximum pumping power available from human muscle working at 8 W/kg would be 0 9 W, equivalent to 4 1/min for the mechanical and hydraulic approaches. The electromechanical approach involves two conversions, and the maximum pumping power available would therefore be 0-45 W, equivalent to 2 1/min. Thus partial assistance of resting heart function is bordering on feasibility with this technique, but the reserve capacity would be limited.
One of the attractions of this general approach is that it would capitalise on the results of an extensive research effort over several years. For example, devices are already available in which the flow has been well characterised and clinical experience has been accumulated. A major advantage of mechanical devices is that they can provide cardiac assistance as soon as they have been connected to the patient's circulation. Thus in the immediate postoperative period it might be possible to energise the device from an external power source, transferring to endogenous power from muscle after the conditioning process had been completed.
A less obvious advantage of using skeletal muscle as the power source for another device is that it eliminates problems of synchrony with the cardiac cycle. We have already stated that during extreme conditioning the shortening velocity for maximum power, Vopt0, expressed in fibre lengths per second, declines to about 25% of control values. Apart from the associated power loss, which has already been referred to, the slowing of contraction and relaxation limits the amount of shortening that can take place within one or other phase of the cardiac cycle.23
Even if the load were optimised to allow the muscle to shorten at V.p, a shortening of 20% would take 400 ms at 0-5 fibre lengths/s. Such considerations become irrelevant if the muscle can be allowed to operate asynchronously.
A major disadvantage of mechanical assist devices is their high cost. This would be increased still further in the case of a device powered by skeletal muscle, which would also require an implantable energy converter and a pacemaker-like neuromuscular stimulator. The long-term success of mechanical circulatory devices is still limited by the biomaterials used in their construction. Materials in current use have a useful life of only about 18 months, but progress in this area has been rapid and this figure could be expected to improve. Reference has already been made to the problems of anchoring the muscle to an artificial device, and the additional problems of leakage associated with a hydraulic system. It is not a trivial anatomical problem to accommodate a mechanical device in the chest when the patient's own heart is still in situ. There is also the problem of finding room for the power converter, although this would be less serious in the case of the electrically driven assist. Finally, all of the existing clinical experience with mechanical circulatory devices has been gained in bridge-to-transplant procedures, and it would be necessary to develop surgical techniques that were not likely to compromise the action of the patient's own heart if such devices were to be used to provide a permanent assist.
Conclusions
When total heart replacement is called for and a transplant is unsuitable or unavailable the mechanical artificial heart is the only option. Mobility, without restraint or encumbrance, should be a major goal of cardiac rehabilitation, so it is appropriate to consider the prospects for implantable devices that are independent of exogenous power sources. We show here that there is little hope of obtaining the energy for such a device entirely from the patient's own skeletal muscle: an electromechanical pump energised in this way would be limited to about 2 
